Text Size

Trial of Efficacy and Safety of Sirolimus in Tuberous Sclerosis and LAM (TESSTAL)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified April 2008 by Cardiff University.
Recruitment status was  Active, not recruiting
Sponsor:
Collaborators:
University of Nottingham
St Georges Hospital Medical School
Royal Sussex County Hospital
The Tuberous Sclerosis Association
Wyeth is now a wholly owned subsidiary of Pfizer
Information provided by:
Cardiff University
ClinicalTrials.gov Identifier:
NCT00490789
First received: June 21, 2007
Last updated: April 29, 2008
Last verified: April 2008
History of Changes
No Study Results Posted on ClinicalTrials.gov for this Study
About Study Results Reporting on ClinicalTrials.gov
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: September 2009
  Estimated Primary Completion Date: September 2009 (Final data collection date for primary outcome measure)
No publications provided by Cardiff University

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):